Journal of Cardiovascular Translational Research

SJR Rank #6,885H-index: 68SJR: 0.802Best quartile: Q1APC: US$4,390
Journal website: aims, scope and author guidelines
Publisher

Springer

Country

United States

Type

journal

SJR by Edition

2022202500.250.50.751

Subject Categories

  • Pharmaceutical ScienceQ1
  • Cardiology and Cardiovascular MedicineQ2
  • GeneticsQ2
  • Genetics (clinical)Q2
  • Molecular MedicineQ2

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Cardiovascular Function and Risk FactorsCardiac Valve Diseases and TreatmentsCardiac Imaging and DiagnosticsCardiac Fibrosis and RemodelingTissue Engineering and Regenerative MedicineCoronary Interventions and DiagnosticsCardiac electrophysiology and arrhythmiasCardiomyopathy and Myosin StudiesCardiac Structural Anomalies and RepairMicroRNA in disease regulation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0100200300400

Documents per Year

2022202504590135180

Detailed Information

ISSN

1937-5395, 1937-5387

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

2.70

References per Document

59.10

Coverage

2008-2026

Scope

Journal of Cardiovascular Translational Research (JCTR) is a premier journal in cardiovascular translational research. JCTR is the journal of choice for authors seeking the broadest audience for emerging technologies, therapies and diagnostics, pre-clinical research, and first-in-man clinical trials. JCTR's intent is to provide a forum for critical evaluation of the novel cardiovascular science, to showcase important and clinically relevant aspects of the new research, as well as to discuss the impediments that may need to be overcome during the translation to patient care.

Metrics from SCImago Journal Rank 2025. View on SCImago